Key points from article :
Results from first-in-human study in lymphoma patients confirm feasibility for toxicity-sparing assessment of drug efficacy in cancer patients.
The study was published in the Science Translational Medicine journal.
Microinjection platform enables assessment of multiple cancer drugs directly in tumors
22-Apr-2015
Mentioned in this article:
Click on resource name for more details.
Fred Hutchinson Cancer Research Center
Cancer Research Center for the elimination of cancer and related diseases
James (Jim) Olson
Pediatric Oncologist, Founder of Presage Biosciences, Blaze Bioscience, and Link Immunotherapeutics.
Rajesh Chopra
Head of the Division of Cancer Therapeutics, Institute of Cancer Research and Royal Marsden Hospital.
Science Translational Medicine
Journal that publish papers with topics related to translational medicine
Read full article on Presage Biosciences website
Topics mentioned on this page:
Cancer
